| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/03/2004 | WO2004045563A2 Method of treatment of myocardial infarction |
| 06/03/2004 | WO2004045560A2 Combination of monounsaturated fatty acids and estogen, and their use |
| 06/03/2004 | WO2004045557A2 Novel lapachone compounds and methods of use thereof |
| 06/03/2004 | WO2004045556A2 Methods for inhibiting allergic inflammation and other responses initiated by pollens, molds, and other non-animal derived allergens |
| 06/03/2004 | WO2004045552A2 Compositions for treating and/or preventing diseases characterized by the presence of metal ions |
| 06/03/2004 | WO2004045551A2 Pharmaceutical composition |
| 06/03/2004 | WO2004045546A2 Water-soluble mesoporphyrin compounds and methods of preparation |
| 06/03/2004 | WO2004045541A2 Soluble isoflavone compositions |
| 06/03/2004 | WO2004045539A2 Anti-microbial agents derived from methionine sulfoximine analogues |
| 06/03/2004 | WO2004045536A2 Method and compositions for temporarily incapaciting subjets |
| 06/03/2004 | WO2004045534A2 Chroman derivatives for the reduction of inflammation symptoms |
| 06/03/2004 | WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/03/2004 | WO2004045528A2 Compositions and method for treating affective, painful or allergic disorders |
| 06/03/2004 | WO2004045523A2 Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders |
| 06/03/2004 | WO2004045518A2 Open chain prolyl urea-related modulators of androgen receptor function |
| 06/03/2004 | WO2004045515A2 Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis |
| 06/03/2004 | WO2004045511A2 Non-steroidal farnesoid x receptor modulators |
| 06/03/2004 | WO2004045510A2 Methods and compositions for alleviating dry eyes |
| 06/03/2004 | WO2004045509A2 Method of using a cox-2 inhibitor and a 5-ht1a receptor modulator as a combination therapy |
| 06/03/2004 | WO2004045508A2 Use of pde4 inhibitors as adjunct therapy for psychiatric disorders |
| 06/03/2004 | WO2004045507A2 Anti-angiogenic uses of il-6 antagonists |
| 06/03/2004 | WO2004045506A2 Conjugated fatty acid based emulsion and methods for preparing and using same |
| 06/03/2004 | WO2004045505A2 Extract of stephaniae sinica diels and methods of using the same |
| 06/03/2004 | WO2004045498A2 Stabilized polyester/cyanoacrylate tissue adhesive formulation |
| 06/03/2004 | WO2004045497A2 Cd26-based therapies for cancers and immune disease |
| 06/03/2004 | WO2004045492A2 Water-soluble anionic bacteriochlorophyll derivatives and their uses |
| 06/03/2004 | WO2004045491A2 Targeted double stranded rna mediated cell killing |
| 06/03/2004 | WO2004045490A2 Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof |
| 06/03/2004 | WO2004045426A1 Method and apparatus for the detection and occlusion of blood vessels |
| 06/03/2004 | WO2004045392A2 Diagnostic method for celiac sprue |
| 06/03/2004 | WO2004045312A1 Agent for inhibiting rise in blood glucose level, agent for inhibiting body fat accumulation and edible material |
| 06/03/2004 | WO2004045307A2 Dietry supplements and foods product comprising oleylethanolamide |
| 06/03/2004 | WO2004037248A3 Modulation of peroxisome proliferator activated receptors activity |
| 06/03/2004 | WO2004035037A3 Derivatives of n-phenylanthranilic acid and 2-benzimidazolon as potassium channel and/or cortical neuron activity modulators |
| 06/03/2004 | WO2004026286A3 Selective phosphodiesterase 9a inhibitors as medicaments for improving cognitive processes |
| 06/03/2004 | WO2004026247A3 Compositions and methods for separating amines and amino acids from their counter-enantiomers |
| 06/03/2004 | WO2004026243A3 Therapeutic uses of linear ketophosphonates |
| 06/03/2004 | WO2004026236A3 Cyclopentyl indole derivatives |
| 06/03/2004 | WO2004024213A3 Aerosolized capreomycin for inhibition of pulmonary tuberculosis |
| 06/03/2004 | WO2004024127A3 Solid formulations comprising an indolinone compound |
| 06/03/2004 | WO2004022060A8 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders |
| 06/03/2004 | WO2004019888A3 Process to prepare psorospermin |
| 06/03/2004 | WO2004019879A3 Motilide compounds |
| 06/03/2004 | WO2004018419A3 Benzimidazole quinolinones and uses thereof |
| 06/03/2004 | WO2004014337A3 A process for the preparation of dispersible tablet of cephalexin |
| 06/03/2004 | WO2004012726A3 Methods for treatment and prevention of gastrointestinal conditions |
| 06/03/2004 | WO2004011005A3 Antimicrobial 2, 4-diamino-pteridine derivatives |
| 06/03/2004 | WO2004009549A3 Piperidines useful for the treatment of central nervous system disorders |
| 06/03/2004 | WO2004006912A3 Combination of an allosteric carboxylic inhibitor of matrix metalloproteinase-13 with celecoxib or valdecoxib |
| 06/03/2004 | WO2004006849A3 Combinations of drugs for the treatment of neoplasms |
| 06/03/2004 | WO2004004603A9 Methods and devices for treating aneurysms |
| 06/03/2004 | WO2004002419A3 Carvedilol phosphate salts and/or solvates thereof, correspondinq compositions, and/or methods of treatment |
| 06/03/2004 | WO2003099228A3 Compositions and processes for inhibiting gene expression using polynucleotides |
| 06/03/2004 | WO2003099194A3 Pharmaceutical combination of pde5 inhibitors with ace inhibitors |
| 06/03/2004 | WO2003092595A3 Tyrosine kinase inhibitors |
| 06/03/2004 | WO2003088761A3 Physiologically compatible, phospholipid-containing, stable and hard matrix |
| 06/03/2004 | WO2003086371A3 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 06/03/2004 | WO2003084937A3 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases |
| 06/03/2004 | WO2003079965A3 Derivatives of isoflavones |
| 06/03/2004 | WO2003075900A3 Utilization of ubiquinones for influencing the effect of histamine |
| 06/03/2004 | WO2003063800A8 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 06/03/2004 | WO2003057159A9 Psoriasin expression by breast epithelial cells |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | WO2003048153A8 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers |
| 06/03/2004 | WO2003045369A3 Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses |
| 06/03/2004 | WO2003041128A3 Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells |
| 06/03/2004 | WO2003039598A8 Selective norepinephrine serotonin reuptake inhibitors for treating fibromyalgia syndrome, chronic fatique syndrome and pain |
| 06/03/2004 | WO2003032995A8 Rosuvastatin in pre demented states |
| 06/03/2004 | WO2003024481A3 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 06/03/2004 | WO2003020739A3 Novel lna compositions and uses thereof |
| 06/03/2004 | WO2003016567A3 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 06/03/2004 | WO2003015706A3 Borinic acid protease inhibitors |
| 06/03/2004 | WO2003004039A3 Composition comprising soy and use thereof in the prevention and/or treatment of various diseases |
| 06/03/2004 | WO2002074315A8 Pharmaceutical combined preparations containing aromatase inhibitors and substances having an estrogen effect in addition to the use thereof for producing a medicament for estrogen-replacement-therapy |
| 06/03/2004 | WO2002070457A8 Inhibitor of monoamine uptake |
| 06/03/2004 | WO2002069950A8 Tumor treatement with a combination of a substrate of mrp5 and modulators of mrp5 |
| 06/03/2004 | WO1997035010A8 Chemokine alpha 2 |
| 06/03/2004 | US20040106864 Method of predicting stroke evolution utilising mri |
| 06/03/2004 | US20040106808 Processes for preparing calanolide a and intermediates thereof |
| 06/03/2004 | US20040106805 optionally oxa-, thia- or hydrocarbylaza-substituted pentalenones, e.g., 3aR, 6aR) 4-tert-Butyl-N-[2-(4-hydroxyphenyl)-1S-(3-oxo-hexahydrocyclopenta[b]furan-3a-ylcChagas' diseasearbamoyl)-ethyl]benzamide; treating Chagas' disease |
| 06/03/2004 | US20040106800 cannabinoid (cb1); treating disorders involving cannabinoid neurotransmission |
| 06/03/2004 | US20040106795 Peptide deformylase inhibitors |
| 06/03/2004 | US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106763 Linear block polymer |
| 06/03/2004 | US20040106730 Polymer complexes of glucuronoglucanes |
| 06/03/2004 | US20040106687 Carotenoids as anti-hypertension agents |
| 06/03/2004 | US20040106686 Antihelminthic anthraquinones and method of use thereof |
| 06/03/2004 | US20040106685 non-steroidal anti-asthmatic agents with very low or negligible side effects |
| 06/03/2004 | US20040106683 show selectivity to the MC1 and MC4 melanocortin receptors as agonists and/or antagonists |
| 06/03/2004 | US20040106682 Novel benzylideneamino guanidines and their uses as ligands to the melnocortin receptors |
| 06/03/2004 | US20040106681 Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders |
| 06/03/2004 | US20040106680 Use of creatine or creatine analogs for the treatment of diseases of the nervous system |
| 06/03/2004 | US20040106679 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 06/03/2004 | US20040106678 calcium and/or magnesium salts of 3-hydroxy-3-methylbutyric acid to prevent and treat disorders caused by or accompanied by hypocalcemia or hypomagnesia |
| 06/03/2004 | US20040106677 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 06/03/2004 | US20040106676 Water-soluble etoposide analogs and methods of use thereof |
| 06/03/2004 | US20040106675 class of compounds generally called the "statins" for use in stimulating bone formation and method to identify compounds useful in this regard by assessing their ability to inhibit enzymes in the pathway of isoprenoid synthesis |
| 06/03/2004 | US20040106673 comprising 12-O-tetradecanoylphorbol-13-acetate and a retinoid or paclitaxel administered together or separately |
| 06/03/2004 | US20040106671 Remedies for vesical hyperesthesia |